πŸ‡ΊπŸ‡Έ FDA
Patent

US 11597707

CGAS antagonist compounds

granted A61KA61K31/381A61K31/426

Quick answer

US patent 11597707 (CGAS antagonist compounds) held by The Board of Regents of the University of Texas System expires Mon Mar 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Mar 07 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
26
CPC classes
A61K, A61K31/381, A61K31/426, A61K31/427, A61K31/429